Ventana Scoffs at Roche's Second Bid Extension; US Court OKs Request to Block 'Anti-Takeover Provisions' | GenomeWeb
NEW YORK (GenomeWeb News) — Roche late yesterday said it has extended the deadline for its $3 billion hostile bid to buy Ventana Medical Systems by almost one month, and Ventana officials quickly responded that the offer remains “wholly inadequate.”
 
Separately today, Roche said that a US District Court granted its request to prevent Ventana from triggering certain “anti-takeover provisions” aimed at killing Roche’s hostile bid.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.